The global bioactive wound care market is expected to reach USD 11.9 billion by 2024, according to a new report by Grand View Research, Inc. The prevalence of chronic skin conditions, such as pressure ulcers, diabetic foot, and other skin-related infections is on the rise. Bioactive wound care products offer available line of treatment, which act efficiently in curing the aforementioned conditions.
Hence, with the increasing target population, the bioactive wound care market is estimated to witness lucrative growth. Rise in awareness among the patients regarding personal hygiene is augmenting the demand for these products. The raised awareness levels cause patients to seek physicians’ advice at an early stage thus enabling timely interventions.
Rising per capita healthcare expenditure in the recent years and the increasing disposable income is enabling the population to spend a substantial amount on healthcare facilities, thereby contributing towards the growth of the market. The development of advanced products, such as combination wound dressings containing multiple ingredients that offer several benefits to patients, is anticipated to boost the demand for these products.
View
summary of this report @ http://www.grandviewresearch.com/industry-analysis/bioactive-wound-care-market
Further key findings from the study suggest:
·
The moist wound care products segment held a
lucrative share of more than 50.0% in 2015. The ability of these products to
create a supportive moist environment, which expedites the healing process, is
a notable feature of these products. Moist wound care products include foams,
films, alginates, hydrocolloids, and hydrogels.
·
The antimicrobials segment, comprising products
impregnated with silver and non-silver ingredients, is anticipated to witness
profitable growth over the forecast period. These products are cost efficient
with lower chances of developing resistance to antimicrobial products.
·
The segment of active wound care products,
likewise, is anticipated to exhibit a significant growth rate in the coming 8
years. Recently, the U.S. Food and Drug Administration approved a couple of
biomaterials, Dermagraft, and Alpigraph, for management of skin-related
injuries. The ability of these products to mimic biological properties is a key
advantage that enables a faster healing process.
·
North America contributed with a share of more
than 30.0% of the global bioactive wound care market. Presence of major
players, streamlined regulations, and favorable reimbursement policies are some
of the key contributing factors responsible for the growth of this region.
·
Asia Pacific with its huge potential is
anticipated to witness considerable growth over the forecast period. The
presence of a huge untapped population, stirring economic developments in this
region, and consistent efforts undertaken to improve the healthcare
infrastructure are the key growth drivers.
·
The key players in this industry include Smiths
& Nephew, Mölnlycke Health Care, ConvaTec, Inc., Paul Hartmann AG,
Organogenesis, Inc., Systagenix Wound Management Ltd., 3M Healthcare Ltd.,
Medtronic, Covalon Technologies Ltd., BSN Medical, and Medline Industries, Inc.
·
The strategic endeavors undertaken by the
leading players in the industry include new product launches, collaborations
with government bodies, and R&D investments.
·
In July 2015, Smith & Nephew acquired DeOst
LLC and DeLLC, part of the DeOST group, which is a manufacturer of medical
devices in Russia. This acquisition is expected to help companies expand their
global footprints.
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented
the global bioactive wound care market on the basis of product and region:
Global Bioactive Wound Care Market,
By Product (USD Million), 2013 - 2024
- Moist Wound Care
- Foams
- Films
- Alginates
- Hydrocolloids
- Hydrogels
- Antimicrobial Wound Care
- Silver-based
- Non-silver-based
- Active Wound Care
- Biomaterials
- Skin substituents
Bioactive Wound Care Market, By
Region (USD Million), 2013 - 2024
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- Asia Pacific
- Japan
- China
- Latin America
- Brazil
- Mexico
- MEA
- South Africa
- Saudi Arabia
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry
James
Corporate
Sales Specialist, U.S.A.
Grand
View Research, Inc.
United
States
Phone: 1-415-349-0058
Toll
Free: 1-888-202-9519
Email: sales@grandviewresearch.com
No comments:
Post a Comment